Critical FDA Alert: Shortage Exception Officially Ended Game-changing federal update: The FDA officially declared the national semaglutide injection shortage resolved on February 21, 2025, effectively ending legal pathways for routine compounding under Section 503A and 503B regulations across all US states
One benefit of SemaPen's subscription service is that your pens arrive automatically when needed
The optional Precision Peptide Genetic Test ($298) reveals your individual metabolic profile across 49 peptides, helping customize your approach for better energy tolerance and faster adaptation
If you have concerns or experience persistent side effects, we can review your treatment plan and help determine the safest next step
Compared to the control Chang liver cells, glucose absorption was enhanced by the Leonotis leonurus extract-nanostructured lipid carriers (NLCs) (131)
ADA, American Diabetes Association